Pharmacologic targets and peritoneal membrane remodeling.

about

Is there such a thing as biocompatible peritoneal dialysis fluid?Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.

P2860

Q38976940-32DED0BE-6371-4715-8236-2463A3A42EEC Q40974170-9135A2A2-9EB3-4E8A-96B8-7FCB416FCFCB

P2860

Pharmacologic targets and peritoneal membrane remodeling.

Item

http://www.wikidata.org/entity/Q38187841

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacologic targets and peritoneal membrane remodeling.

@en

type

Item

label

Pharmacologic targets and peritoneal membrane remodeling.

@en

prefLabel

Pharmacologic targets and peritoneal membrane remodeling.

@en

P1476

Pharmacologic targets and peritoneal membrane remodeling.

@en

P2093

Andrea W D Stavenuiter

http://www.w3.org/2001/XMLSchema#string

Karima Farhat

http://www.w3.org/2001/XMLSchema#string

Piet M Ter Wee

http://www.w3.org/2001/XMLSchema#string

Rob H J Beelen

http://www.w3.org/2001/XMLSchema#string

P2860

Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy

Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice

Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.

Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat.

The role of cyclooxygenases in inflammation, cancer, and development.

Vitamin D analogs: perspectives for treatment.

Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system.

Pathophysiology of peritoneal membrane failure.

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

P304

114-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/PDI.2011.00332

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260195379

http://www.w3.org/2001/XMLSchema#string

P698

24525599

http://www.w3.org/2001/XMLSchema#string

P932

3923701

http://www.w3.org/2001/XMLSchema#string

Pharmacologic targets and peritoneal membrane remodeling.

about

P2860

P2860

Pharmacologic targets and peritoneal membrane remodeling.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932